Neuphoria Therapeutics share price logo

Neuphoria Therapeutics

NASDAQ: NEUP

$2.27

-0.21

(-8.27%)

as on

Neuphoria Therapeutics Stock Performance

as on November 18, 2026 at 7:59 am IST

  • Day's High

    $2.27
    $2.51

    10.57%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.45
    $5.53
    downward going graph

    -7.93%

    Downside

    143.61%

    Upside

    downward going graph

Neuphoria Therapeutics share price movements today

Previous Close
$2.48
Open
$2.51
Volume
243.7K
Market Cap
$13.8M
Day's Low - High
$2.27 - $2.51
52 Week Low - High
$2.45 - $5.53

Neuphoria Therapeutics Historical Returns

1 Month Return
-24.85 %
3 Month Return
-35.58 %
1 Year Return
-47.23 %
3 Year Return
0 %
5 Year Return
0 %

Neuphoria Therapeutics Stock Fundamentals & Key Indicators

Check Neuphoria Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.8M

EPS (TTM)

-7.2633

Dividend Yield

0.00%

PE Ratio (TTM)

-0.35

Industry PE ratio

-2.76

PEG Ratio

-0.00

Return On Equity TTM

-77.03%

Neuphoria Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neuphoria Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$13.8MNA-0.3543.54%0.00%
Neutral$100.6B0.07%-35.1828.00%0.00%
StrongBuy$47.6BNA67.0788.39%0.00%
StrongBuy$136.6B185.68%34.3985.57%0.00%
Buy$98.8B48.39%20.3585.77%0.39%

Stock Returns calculator for Neuphoria Therapeutics Stock including INR - Dollar returns

The Neuphoria Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Neuphoria Therapeutics investment value today

Current value as on today

₹50,926

Returns

-₹49,074

(-49.07%)

Returns from Neuphoria Therapeutics Stock

-₹51,702 (-51.7%)

Dollar Impact

₹2,629 (+2.63%)

Indian Investors' Interest in Neuphoria Therapeutics Stock

Search interest for Neuphoria Therapeutics Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-25% versus previous 30 day period

Neuphoria Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
10
0
15
-10
-
-
-
1
Gross Profit
0
0
0
0
15
-10
0
0
0
1
Operating Income
-5
-8
-3
2
11
-10
-8
-4
-1
0
EBITDA
-5
-8
-5
2
12
-10
-8
-
-1
0
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-6
14
0
-1
11
-15
-15
1
0
-4
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
11
-2
0
-1
11
-14
-14
1
0
-4
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
100.00%
100.00%
0.00%
0.00%
0.00%
85.89%

Neuphoria Therapeutics Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Total Revenue
27
11
7
0
0
0
-
-
15
1
Gross Profit
2
-13
2
0
-1
-9
0
0
14
0
Operating Income
-13
-21
-10
-6
-8
-31
-33
-26
-1
-9
EBITDA
-3
-22
-11
-1
-4
-30
-31
-25
0
-9
Interest Expense
1
1
1
1
1
0
-
-
-
-
Depreciation
1
1
1
1
1
1
0
0
0
0
Income Before Tax
-4
-19
-6
-4
-6
-31
-32
-15
0
-13
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-5
-18
-6
-4
-6
-22
-32
-15
0
-13
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
95.76%
43.54%

Neuphoria Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-4
-2
0
-1
11
-378
-9
1
0
-4
Operating Cash Flow
-5
-3
-4
-3
11
73
-3
-6
-3
1
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
2
7
0
0
1
0
3
14
-
0
Change in Cash
-2
4
-4
-3
12
14,271
0
8
-2
0

Neuphoria Therapeutics Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Net Income
-
-
-10
-4
-6
-21
-14
-15
-369
-13
Operating Cash Flow
-1
-15
-10
-2
-5
-21
-9
-14
77
-12
Investing Cash Flow
0
0
0
0
0
0
-
-
-
-
Financing Cash Flow
-2
1
3
-3
23
26
5
15
1,528
17
Change in Cash
-2
-13
-7
-6
17
5
-15
0
1,601
5

Global Institutional Holdings in Neuphoria Therapeutics

Check out the Institutions with significant holdings in Neuphoria Therapeutics.

Funds
Holdings
AdvisorShares
5.37%
VANGUARD INDEX FUNDS
3.21%
Vanguard
3.21%
Fidelity Concord Street Trust
0.99%

Insights on Neuphoria Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -13.26K → 1.17M (in $), with an average increase of 101.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 763.8% return, outperforming this stock by 811.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 1.86M → -4.90M (in $), with an average decrease of 499.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, NEUP stock has moved down by -24.8%

About Neuphoria Therapeutics

Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, develops novel allosteric ion channel modulators for patients with serious central nervous system disorders in Australia. Its lead product candidate is BNC210, an oral, proprietary, selective negative allosteric modulator of the alpha7 nicotinic acetylcholine receptor for post-traumatic stress disorder. The company also develops Merck alpha7 positive allosteric modulators. It has a research collaboration and license agreement with Merck & Co., Inc. to develop alpha7 receptor positive allosteric modulators targeting cognitive dysfunction associated with Alzheimer's disease and other central nervous system conditions. The company was formerly known as Bionomics Limited and changed its name to Neuphoria Therapeutics Inc. in December 2024. Neuphoria Therapeutics Inc. was incorporated in 1996 and is based in Millis, Massachusetts.
OrganisationNeuphoria Therapeutics
Headquarters14 Milliston Road, Millis, MA, 02054, US
IndustryBiotechnology
CEOSpyridon Papapetropoulos

Key Management of Neuphoria Therapeutics

Name

Title

Dr. Spyridon Papapetropoulos M.D., Ph.D.

Interim CEO & Executive Director

Mr. Timothy M. Cunningham CPA, M.B.A.

Fractional CFO

Dr. Julie Kerner Ph.D.

Senior Vice President of Business Operations

Mr. Adrian Hinton BEC, F.C.A.

Financial Controller

Mr. Rajeev Chandra B.Com., C.A., M.B.A.

Company Secretary

FAQs

What is Neuphoria Therapeutics share price today?

Neuphoria Therapeutics share price today is $2.27 as on at the close of the market. Neuphoria Therapeutics share today touched a day high of $2.51 and a low of $2.27.

What is the 52 week high and 52 week low for Neuphoria Therapeutics share?

Neuphoria Therapeutics share touched a 52 week high of $5.53 on and a 52 week low of $2.45 on . Neuphoria Therapeutics stock price today i.e. is closed at $2.27,which is 58.95% down from its 52 week high and -7.35% up from its 52 week low.

What is Neuphoria Therapeutics's market capitalisation today?

Neuphoria Therapeutics market capitalisation is $0.00T as on .

How to invest in Neuphoria Therapeutics Stock (NEUP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neuphoria Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Neuphoria Therapeutics Stock (NEUP) from India?

Indian investors can start investing in Neuphoria Therapeutics (NEUP) shares with as little as ₹93.459999084473 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹934.60 in Neuphoria Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Neuphoria Therapeutics share’s latest price of $2.27 as on November 18, 2026 at 2:29 am IST, you will get 4.4053 shares of Neuphoria Therapeutics. Learn more about fractional shares .